BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Real-time Estimate Cboe BZX  -  11:47 2022-06-28 am EDT
248.73 USD   -0.55%
06/24Wells Fargo Upgrades Becton Dickinson and Co. to Overweight From Equalweight; Price Target is $275
MT
06/23Becton, Dickinson and Company Recalls Intraosseous Products
MT
06/22BD Voluntarily Recalling Intraosseous Products
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Transcript : Becton, Dickinson and Company, Q2 2022 Earnings Call, May 05, 2022

05/05/2022 | 08:00am EDT
Hello and welcome to BD's Earning Call for the Second Quarter of Fiscal 2022. At the request of BD, today's call is being recorded and will be available for replay through May 12, 2022, on BD's...


© S&P Capital IQ 2022
All news about BECTON, DICKINSON AND COMPANY
06/24Wells Fargo Upgrades Becton Dickinson and Co. to Overweight From Equalweight; Price Tar..
MT
06/23Becton, Dickinson and Company Recalls Intraosseous Products
MT
06/22BD Voluntarily Recalling Intraosseous Products
DJ
06/22BD Announces Voluntary Recall on Intraosseous Products
CI
06/22Eastern Health and BD Implement Innovative Solution with Goal of Reducing Consumption o..
AQ
06/22Eastern Health and Becton, Dickinson and Company Implement Innovative Solution with Goa..
CI
06/16TRANSCRIPT : Becton, Dickinson and Company Presents at Goldman Sachs 43rd Annual Global He..
CI
06/13BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Impro..
PR
06/13BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Impro..
CI
06/09INSIDER SELL : Becton Dickinson
MT
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 18 682 M - -
Net income 2022 1 741 M - -
Net Debt 2022 13 463 M - -
P/E ratio 2022 38,4x
Yield 2022 1,52%
Capitalization 71 295 M 71 295 M -
EV / Sales 2022 4,54x
EV / Sales 2023 4,29x
Nbr of Employees 75 000
Free-Float 77,5%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 250,10 $
Average target price 280,50 $
Spread / Average Target 12,2%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher J. DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY2.10%71 528
ABBOTT LABORATORIES-22.23%191 641
MEDTRONIC PLC-12.79%119 876
BAXTER INTERNATIONAL INC.-22.20%33 626
HOYA CORPORATION-29.46%31 948
AMERISOURCEBERGEN CORPORATION11.72%31 097